Terms: = Lung cancer AND B2M, P61769, 567, ENSG00000166710 AND Diagnosis
40 results:
1. Downregulated circ_0001681 Predicts the Occurrence and Malignant Development of lung Carcinoma via Negatively Modulating miR-567.
Li M; Mao C; Li W; Xia W; Li K; Xu R
Ann Clin Lab Sci; 2023 Nov; 53(6):881-889. PubMed ID: 38182148
[TBL] [Abstract] [Full Text] [Related]
2. Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy.
Rittberg R; Leung B; Shokoohi A; Pender A; Wong S; Al-Hashami Z; Wang Y; Ho C
Curr Oncol; 2023 May; 30(6):5299-5308. PubMed ID: 37366885
[TBL] [Abstract] [Full Text] [Related]
3. Estimating time and transportation costs associated with lung cancer screening and diagnostic lung procedures in Taiwan: a cross-sectional survey in a medical centre.
Wu CH; Ku LE; Lin CY; Chung TJ; Liu HJ; Chao TH; Yang SC
BMJ Open; 2023 Mar; 13(3):e070647. PubMed ID: 36898750
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic prediction of lung adenocarcinoma by integrative analysis of RHOH expression and methylation.
Kuang M; Zhou Z; Lu Z; Shen W; Ge H; Tao X; Zhao Y; Zhuge L; Sun Y; Ji D; Zhang H
Clin Respir J; 2023 Mar; 17(3):148-156. PubMed ID: 36710485
[TBL] [Abstract] [Full Text] [Related]
5. Oxidized Regenerated Cellulose (Surgicel®) on Cytology/Histology.
Kurian EM; Abu-Hijleh M; Lowrey TR; De Las Casas LE
Acta Cytol; 2022; 66(6):556-559. PubMed ID: 35896064
[TBL] [Abstract] [Full Text] [Related]
6. Increasing Time-to-Treatment for lung cancer: Are We Going Backward?
Muslim Z; Stroever S; Razi SS; Poulikidis K; Baig MZ; Connery CP; Bhora FY
Ann Thorac Surg; 2023 Jan; 115(1):192-199. PubMed ID: 35780818
[TBL] [Abstract] [Full Text] [Related]
7. Automatic creation of annotations for chest radiographs based on the positional information extracted from radiographic image reports.
Wang B; Takeda T; Sugimoto K; Zhang J; Wada S; Konishi S; Manabe S; Okada K; Matsumura Y
Comput Methods Programs Biomed; 2021 Sep; 209():106331. PubMed ID: 34418813
[TBL] [Abstract] [Full Text] [Related]
8. Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression.
Giroux Leprieur E; Hélias-Rodzewicz Z; Takam Kamga P; Costantini A; Julie C; Corjon A; Dumenil C; Dumoulin J; Giraud V; Labrune S; Garinet S; Chinet T; Emile JF
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581058
[TBL] [Abstract] [Full Text] [Related]
9. Linear mixed-effects models for estimation of pulmonary metastasis growth rate: implications for CT surveillance in patients with sarcoma.
Isidro U; O'Brien LM; Sebro R
Br J Radiol; 2020 Oct; 93(1114):20190856. PubMed ID: 32559116
[TBL] [Abstract] [Full Text] [Related]
10. Analysis of Progression Patterns and Failure Sites of Patients With Metastatic lung Adenocarcinoma With EGFR Mutations Receiving First-line Treatment of Tyrosine Kinase Inhibitors.
Li XY; Zhu XR; Zhang CC; Yu W; Zhang B; Shen TL; Zhang HY; Fu XL
Clin Lung Cancer; 2020 Nov; 21(6):534-544. PubMed ID: 32505632
[TBL] [Abstract] [Full Text] [Related]
11. Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With cancer.
Seow H; Tanuseputro P; Barbera L; Earle C; Guthrie D; Isenberg S; Juergens R; Myers J; Brouwers M; Sutradhar R
JAMA Netw Open; 2020 Apr; 3(4):e201768. PubMed ID: 32236529
[TBL] [Abstract] [Full Text] [Related]
12. Air Pollution and Incidence of lung cancer by Histological Type in Korean Adults: A Korean National Health Insurance Service Health Examinee Cohort Study.
Moon DH; Kwon SO; Kim SY; Kim WJ
Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32024216
[No Abstract] [Full Text] [Related]
13. CYFRA21-1 tests in the diagnosis of non-small cell lung cancer: A meta-analysis.
Fu L; Wang R; Yin L; Shang X; Zhang R; Zhang P
Int J Biol Markers; 2019 Sep; 34(3):251-261. PubMed ID: 31436122
[TBL] [Abstract] [Full Text] [Related]
14. Compensated Interferometry Measures of CYFRA 21-1 Improve diagnosis of lung cancer.
Kammer MN; Kussrow AK; Webster RL; Chen H; Hoeksema M; Christenson R; Massion PP; Bornhop DJ
ACS Comb Sci; 2019 Jun; 21(6):465-472. PubMed ID: 31022347
[TBL] [Abstract] [Full Text] [Related]
15. [Correlation between Plasma D-dimer Count and Features of
Non-small Cell lung cancer].
Song X; Wang F; Shen H; Li J; Hu T; Yang Z; Zhou Y; Shi Q
Zhongguo Fei Ai Za Zhi; 2019 Mar; 22(3):151-156. PubMed ID: 30909994
[TBL] [Abstract] [Full Text] [Related]
16. Long-term Somatic Disease Risk in Adult Danish cancer Survivors.
Kjaer TK; Andersen EAW; Winther JF; Bidstrup PE; Borre M; Møller H; Larsen SB; Johansen C; Dalton SO
JAMA Oncol; 2019 Apr; 5(4):537-545. PubMed ID: 30844031
[TBL] [Abstract] [Full Text] [Related]
17. Deep learning for chest radiograph diagnosis: A retrospective comparison of the CheXNeXt algorithm to practicing radiologists.
Rajpurkar P; Irvin J; Ball RL; Zhu K; Yang B; Mehta H; Duan T; Ding D; Bagul A; Langlotz CP; Patel BN; Yeom KW; Shpanskaya K; Blankenberg FG; Seekins J; Amrhein TJ; Mong DA; Halabi SS; Zucker EJ; Ng AY; Lungren MP
PLoS Med; 2018 Nov; 15(11):e1002686. PubMed ID: 30457988
[TBL] [Abstract] [Full Text] [Related]
18. [Radical nephrectomy and thrombectomy for Mayo clinic stage III tumor thrombus: a surgical technique and clinical experience].
Liu Z; Ma LL; Tian XJ; Wang GL; Hou XF; Zhang SD; Deng SH
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):597-604. PubMed ID: 28816272
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic MicroRNA Biomarker Discovery for Non-Small-Cell lung cancer Adenocarcinoma by Integrative Bioinformatics Analysis.
Shao Y; Liang B; Long F; Jiang SJ
Biomed Res Int; 2017; 2017():2563085. PubMed ID: 28698868
[TBL] [Abstract] [Full Text] [Related]
20. CT Screening for lung cancer: Part-Solid Nodules in Baseline and Annual Repeat Rounds.
Henschke CI; Yip R; Smith JP; Wolf AS; Flores RM; Liang M; Salvatore MM; Liu Y; Xu DM; Yankelevitz DF;
AJR Am J Roentgenol; 2016 Dec; 207(6):1176-1184. PubMed ID: 27726410
[TBL] [Abstract] [Full Text] [Related]
[Next]
